Patrick Plésiat (P Plésiat)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 13

Top Topics

Pseudomonas Aeruginosa

Cystic Fibrosis

Top Venues

Antimicrobial agents and chemotherapy

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Microbiology spectrum

This page only lists publications with an associated author ORCID identifier.

Publications

J Couchot, D Fournier, M Bour, L Rajeev, P Rhodes, P Singh, K Jeannot, Patrick Plésiat
Evaluation of the Reveal® rapid AST system to assess the susceptibility of Pseudomonas aeruginosa from blood cultures. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2023)
J Couchot, D Fournier, M Bour, L Rajeev, P Rhodes, P Singh, K Jeannot, Patrick Plésiat
Evaluation of the Reveal® rapid AST system to assess the susceptibility of Pseudomonas aeruginosa from blood cultures. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 42 (3) (2023)
Aya Ghassani, Pauline Triponney, Maxime Bour, Patrick Plésiat, Katy Jeannot, null null
Mutations in genes lpxL1 , bamA , and pmrB impair the susceptibility of cystic fibrosis strains of Pseudomonas aeruginosa to murepavadin. Antimicrobial agents and chemotherapy (2023)
J Couchot, D Fournier, M Bour, L Rajeev, P Rhodes, P Singh, K Jeannot, Patrick Plésiat
Evaluation of the Reveal® rapid AST system to assess the susceptibility of Pseudomonas aeruginosa from blood cultures. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 42 (3) (2023)
J Couchot, D Fournier, M Bour, L Rajeev, P Rhodes, P Singh, K Jeannot, Patrick Plésiat
Evaluation of the Reveal® rapid AST system to assess the susceptibility of Pseudomonas aeruginosa from blood cultures. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 42 (3) (2023)
Vincent Le Moigne, Anne-Laure Roux, Hélène Mahoudo, Gaëtan Christien, Agnès Ferroni, Oana Dumitrescu, Gérard Lina, Jean-Philippe Bouchara, Patrick Plésiat, Jean-Louis Gaillard, Stéphane Canaan, Geneviève Héry-Arnaud, Jean-Louis Herrmann
IgA Serological Response for the Diagnosis of Mycobacterium abscessus Infections in Patients with Cystic Fibrosis. Microbiology spectrum 10 (3) (2022)
Damien Fournier, Romain Carrière, Maxime Bour, Emilie Grisot, Pauline Triponney, Cédric Muller, Jérôme Lemoine, Katy Jeannot, Patrick Plésiat, null null
Mechanisms of Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa: Results of the GERPA Multicenter Study. Antimicrobial agents and chemotherapy 65 (2) (2021)
Andrew R Mack, Melissa D Barnes, Magdalena A Taracila, Andrea M Hujer, Kristine M Hujer, Gabriel Cabot, Michael Feldgarden, Daniel H Haft, William Klimke, Focco van den Akker, Alejandro J Vila, Andrea Smania, Shozeb Haider, Krisztina M Papp-Wallace, Patricia A Bradford, Gian Maria Rossolini, Jean-Denis Docquier, Jean-Marie Frère, Moreno Galleni, Nancy D Hanson, Antonio Oliver, Patrick Plésiat, Laurent Poirel, Patrice Nordmann, Timothy G Palzkill, George A Jacoby, Karen Bush, Robert A Bonomo
A Standard Numbering Scheme for Class C β-Lactamases. Antimicrobial agents and chemotherapy 64 (3) (2020)
Hélène Puja, Arnaud Bolard, Aurélie Noguès, Patrick Plésiat, Katy Jeannot
The Efflux Pump MexXY/OprM Contributes to the Tolerance and Acquired Resistance of Pseudomonas aeruginosa to Colistin. Antimicrobial agents and chemotherapy 64 (4) (2020)
Anais Potron, Damien Fournier, Cécile Emeraud, Pauline Triponney, Patrick Plésiat, Thierry Naas, Laurent Dortet
Evaluation of the Immunochromatographic NG-Test Carba 5 for Rapid Identification of Carbapenemase in Nonfermenters. Antimicrobial agents and chemotherapy 63 (9) (2019)
Arnaud Bolard, Monika Schniederjans, Susanne Haüssler, Pauline Triponney, Benoît Valot, Patrick Plésiat, Katy Jeannot
Production of Norspermidine Contributes to Aminoglycoside Resistance in pmrAB Mutants of Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy 63 (10) (2019)
Alexandre Tetard, Andy Zedet, Corine Girard, Patrick Plésiat, Catherine Llanes
Cinnamaldehyde Induces Expression of Efflux Pumps and Multidrug Resistance in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy 63 (10) (2019)
François Guérin, François Gravey, Patrick Plésiat, Marion Aubourg, Racha Beyrouthy, Richard Bonnet, Vincent Cattoir, Jean-Christophe Giard
The Transcriptional Repressor SmvR Is Important for Decreased Chlorhexidine Susceptibility in Enterobacter cloacae Complex. Antimicrobial agents and chemotherapy 64 (1) (2019)